Article ID Journal Published Year Pages File Type
8228107 International Journal of Radiation Oncology*Biology*Physics 2012 9 Pages PDF
Abstract
Despite the acceptable toxicity, thalidomide provided no additional benefit for HCC patients undergoing RT.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Phase II Study of Concomitant Thalidomide During Radiotherapy for Hepatocellular Carcinoma
Authors
, , , , , , , , ,